Actinogen Medical (ACW)
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders. The company was founded by David Keast on March 23, 1999 and is headquartered in West Perth, Australia.
|Market Price at 22-11-2017||$0.06|
|Price to Earnings Ratio||-11.45|
|Market Capitalisation||$34.11 (million)|
|Return on Equity (ROE)||-34.04%|